Tumstatin Assay

Patent Number: US-20230052142-A1

Publication Year: 2023

Application Year: 2022

Priority Year: 2017

Jurisdictions: US

Status: Pending

Inventors:

NIELSEN SIGNE HOLM KARSDAL MORTEN GENOVESE FEDERICA

Applicants:

  1. Nordic Bioscience (Denmark)
  2. [NORA names: Nordic Bioscience; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

The present invention relates to an assay for detecting Tumstatin, and its use in evaluating lung cancers, such as non-small cell lung cancer (NSCLC), chronic kidney disease (CKD), such as CKD resulting from diabetes, lupus nephritis (LN) and systemic lupus erythematosus (SLE).

Patent Family Records (1)

Tumstatin Assay

Nordic Bioscience (Denmark), Nordic Bioscience AS NIELSEN SIGNE HOLM, KARSDAL MORTEN, GENOVESE FEDERICA

2023, US-20230052142-A1

Data Provider: Digital Science